{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:23Z","timestamp":1790268683049,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.autrev.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T11:46:37Z","timestamp":1424519197000},"page":"594-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["P-glycoprotein in autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"M.","family":"Garc\u00eda-Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mendoza-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Macias D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vera-Recabarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"V\u00e1zquez de Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"M\u00e9ndez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Soto-Santill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gonz\u00e1lez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ruiz-Arguelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.3390\/ijms15034965","article-title":"P-glycoprotein and drug resistance in systemic autoimmune diseases","volume":"15","author":"Picchianti-Diamanti","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2015.02.006_bb0010","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s11033-014-3173-y","article-title":"Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population","volume":"41","author":"Zhang","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"12","key":"10.1016\/j.autrev.2015.02.006_bb0015","first-page":"930","article-title":"MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus","volume":"62","author":"Yang","year":"2007","journal-title":"Pharmazie"},{"issue":"12","key":"10.1016\/j.autrev.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/cncr.22332","article-title":"Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T\/A gene polymorphism is associated with high risk of lung cancer","volume":"107","author":"Gervasini","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.autrev.2015.02.006_bb0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1590\/S0100-879X2008000900005","article-title":"ABCB1 C1236T, G2677T\/A and C3435T polymorphisms in systemic lupus erythematosus patients","volume":"41","author":"Gonzalez","year":"2008","journal-title":"Braz J Med Biol Res"},{"issue":"5811","key":"10.1016\/j.autrev.2015.02.006_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.autrev.2015.02.006_bb0035","series-title":"Multidrug Resistance Protein (P-Glycoprotein; MDR1) Department of Molecular and Cellular Biology","author":"Sharom","year":"2005"},{"issue":"5","key":"10.1016\/j.autrev.2015.02.006_bb0040","first-page":"546","article-title":"ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients","volume":"24","author":"Takatori","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.02.006_bb0045","first-page":"187","article-title":"Procesos biomoleculares de la resistencia a drogas","volume":"1","author":"S\u00e1nchez--Suarez","year":"2006","journal-title":"Cancerolog\u00eda"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/mp050113v","article-title":"Breast cancer resistance protein (Bcrp\/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse","volume":"3","author":"Zaher","year":"2006","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.24354","article-title":"Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide","volume":"60","author":"van der Heijden","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.108.023200","article-title":"Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone","volume":"37","author":"Lagas","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"4617","key":"10.1016\/j.autrev.2015.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.6137059","article-title":"Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines","volume":"221","author":"Kartner","year":"1983","journal-title":"Science"},{"issue":"7137","key":"10.1016\/j.autrev.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","article-title":"Major facilitator superfamily","volume":"62","author":"Pao","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"issue":"6","key":"10.1016\/j.autrev.2015.02.006_bb0080","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.21032","article-title":"Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus","volume":"52","author":"Tsujimura","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10157-011-0520-3","article-title":"Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease","volume":"16","author":"Tsujimura","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"10.1016\/j.autrev.2015.02.006_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2177\/jsci.29.319","article-title":"Multi-drug resistance in the treatments of autoimmune diseases","volume":"29","author":"Tanaka","year":"2006","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0095","first-page":"30","article-title":"Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome","volume":"67","author":"Llorente","year":"2000","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-4652(199809)176:3<506::AID-JCP7>3.0.CO;2-S","article-title":"Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures","volume":"176","author":"Hirsch-Ernst","year":"1998","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2003.08.002","article-title":"P-glycoprotein in autoimmune diseases","volume":"3","author":"Richaud-Patin","year":"2004","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2015.02.006_bb0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2190\/2ELG-RDUN-X6TU-FGC8","article-title":"Effects of mood state and psychosocial functioning on plasma Interleukin-6 in adult patients before cardiac surgery","volume":"35","author":"Ai","year":"2005","journal-title":"Int. J Psychiatry Med"},{"key":"10.1016\/j.autrev.2015.02.006_bb0115","first-page":"437","article-title":"Funcionalidad de la glicoproteina p linfocitaria en la colitis ulcerosa","volume":"69","author":"Cortada","year":"2009","journal-title":"Medicina (B Aires)"},{"issue":"4","key":"10.1016\/j.autrev.2015.02.006_bb0120","first-page":"638","article-title":"Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus","volume":"26","author":"Lu","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/S0103-84782006000100056","article-title":"Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs","volume":"36","author":"Linardi","year":"2006","journal-title":"Ci\u00eanc Rural"},{"issue":"2","key":"10.1016\/j.autrev.2015.02.006_bb0130","first-page":"111","article-title":"Resistencia a drogas mediada por la glicoprote\u00edna p","volume":"14","author":"Fern\u00e1ndez","year":"1998","journal-title":"Rev Cuba Oncol"},{"issue":"5922","key":"10.1016\/j.autrev.2015.02.006_bb0135","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.autrev.2015.02.006_bb0140","first-page":"619","article-title":"Lymphocyte P-glycoprotein variability in healthy individuals","volume":"69","author":"Cortada","year":"2009","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0145","first-page":"40","article-title":"Papel de las prote\u00ednas de membrana en la resistencia al tratamiento m\u00e9dico de la epilepsia","volume":"12","author":"Ospina","year":"2006","journal-title":"Rev Med Risaralda"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3899\/jrheum.090048","article-title":"Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis","volume":"37","author":"Suzuki","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.02.006_bb0155","first-page":"97","article-title":"Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis","volume":"44","author":"Salmon","year":"1996","journal-title":"J Rheumatol Suppl"},{"issue":"12","key":"10.1016\/j.autrev.2015.02.006_bb0160","first-page":"2345","article-title":"Clinical implication of cyclosporin for rheumatoid arthritis","volume":"60","author":"Tanaka","year":"2002","journal-title":"Nihon Rinsho"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1744-9987.1997.tb00140.x","article-title":"The mechanism of the efficiency of leukocytapheresis on rheumatoid arthritis","volume":"1","author":"Hidaka","year":"1997","journal-title":"Ther Apher"},{"issue":"2","key":"10.1016\/j.autrev.2015.02.006_bb0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jgm.1378","article-title":"MDR1a\/1b gene silencing enhances drug sensitivity in rat fibroblast-like synoviocytes","volume":"12","author":"Honjo","year":"2010","journal-title":"J Gene Med"},{"issue":"2","key":"10.1016\/j.autrev.2015.02.006_bb0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0005-2736(94)90190-2","article-title":"Calcein accumulation as a fluorometric functional assay of the multidrug transporter","volume":"1191","author":"Holl\u00f3","year":"1994","journal-title":"Biochim Biophys Acta"},{"issue":"29","key":"10.1016\/j.autrev.2015.02.006_bb0180","doi-asserted-by":"crossref","first-page":"21493","DOI":"10.1016\/S0021-9258(20)80566-3","article-title":"Fluorescent cellular indicators are extruded by the multidrug resistance protein","volume":"268","author":"Homolya","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.autrev.2015.02.006_bb0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/excr.1994.1146","article-title":"Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833","volume":"212","author":"Liminga","year":"1994","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2015.02.006_bb0190","series-title":"Selection of healthy volunteers according to their MDR-1 activity does not affect bioavailability of quetiapine","author":"Guzm\u00e1n-Ruiz","year":"2015"},{"issue":"8","key":"10.1016\/j.autrev.2015.02.006_bb0195","first-page":"486","article-title":"Osteoporosis in patients with systemic lupus erythematosus","volume":"11","author":"Garc\u00eda-Carrasco","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2015.02.006_bb0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.reuma.2013.04.013","article-title":"Registro nacional de pacientes con lupus eritematoso sist\u00e9mico de la Sociedad Espa\u00f1ola de Reumatolog\u00eda: objetivos y metodolog\u00eda","volume":"10","author":"R\u00faa-Figueroa","year":"2014","journal-title":"Reumatol Clin"},{"issue":"5","key":"10.1016\/j.autrev.2015.02.006_bb0205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1248\/bpb.31.873","article-title":"P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus","volume":"31","author":"Henmi","year":"2008","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.autrev.2015.02.006_bb0210","first-page":"101","article-title":"P-glycoprotein-1 functional activity in CD5+CD7+ and CD20+ lymphocytes in systemic lupus erythematosus children: relation to disease activity, complications and steroid response","volume":"20","author":"Ragab","year":"2013","journal-title":"Egypt J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0215","first-page":"40","article-title":"Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control","volume":"67","author":"Diaz-Borjon","year":"2000","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0220","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/s10165-004-0354-x","article-title":"Overcoming treatment unresponsiveness mediated by P-glycoprotein overexpression on lymphocytes in refractory active systemic lupus erythematosus","volume":"15","author":"Tsujimura","year":"2005","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0961203313519159","article-title":"Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy","volume":"23","author":"Sakthiswary","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2015.02.006_bb0230","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.reuma.2014.01.009","article-title":"Papel del factor de crecimiento transformador-beta (TGF-\u03b2) en la fisiopatolog\u00eda de la artritis reumatoide","volume":"10","author":"Gonzalo-Gila","year":"2014","journal-title":"Reumatol Clin"},{"issue":"5","key":"10.1016\/j.autrev.2015.02.006_bb0235","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/rheumatology\/35.5.430","article-title":"Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone","volume":"35","author":"Maillefert","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2015.02.006_bb0240","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2007.070821","article-title":"Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis","volume":"67","author":"Tsujimura","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2015.02.006_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/s10165-009-0247-0","article-title":"Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis","volume":"20","author":"Tsujimura","year":"2010","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2015.02.006_bb0250","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5414\/CPP42496","article-title":"The MDR1 3435 polymorphism in patients with rheumatoid arthritis","volume":"42","author":"Pawlik","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.autrev.2015.02.006_bb0255","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00228-006-0192-1","article-title":"The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs","volume":"62","author":"Drozdzik","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.autrev.2015.02.006_bb0260","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00228-008-0521-7","article-title":"Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism","volume":"64","author":"Bohanec Grabar","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.autrev.2015.02.006_bb0265","series-title":"Harison\u00b4s Principles of Internal Medicina","first-page":"1072","year":"2013"},{"issue":"1","key":"10.1016\/j.autrev.2015.02.006_bb0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2010.10.001","article-title":"Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function","volume":"138","author":"Diamanti","year":"2011","journal-title":"Clin Immunol"},{"issue":"9678","key":"10.1016\/j.autrev.2015.02.006_bb0275","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.autrev.2015.02.006_bb0280","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5414\/CP202098","article-title":"Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients","volume":"52","author":"Samara","year":"2014","journal-title":"Int J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2015.02.006_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.urolonc.2008.01.011","article-title":"P-glycoprotein activity in renal clear cell carcinoma","volume":"27","author":"Soto-Vega","year":"2009","journal-title":"Urol Oncol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T06:18:17Z","timestamp":1717741097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215000506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1568997215000506"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.02.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P-glycoprotein in autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}